Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel synthesis of 2,6-dichloro-4,8-dipiperidinopyrimido[5,4-D]pyrimidine using selective tosylation and microwave chlorination ensures >99% purity and scalable manufacturing for global supply chains.
Advanced synthesis of Gefitinib intermediates via CN102146060A. Eco-friendly route eliminates halogenating agents, ensuring high purity and cost reduction in API manufacturing.
Patent CN109824665B details a novel oxidative coupling method for synthesizing imidazopyridine sulfonamides using methanol, offering cost-effective routes for pharmaceutical intermediates.
Patent CN112266364B reveals metal-free hydrogenation for tetrahydroquinoxaline. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing without transition metals.
Patent CN1177839C details a robust Quetiapine synthesis avoiding unstable intermediates. This report analyzes cost reduction and scalability for pharmaceutical manufacturing.
Patent CN102399163B reveals a high-yield 4-step route to Chloramphenicol using 4-chlorobenzaldehyde, eliminating resolution and reducing waste for reliable API intermediate supply.
Novel silver-catalyzed oxidative cyclization for high-purity imidazo[1,2-a]pyridine. Reduces cost and improves supply chain reliability for pharmaceutical manufacturing.
Patent CN106518839A enables safe 2-thiopheneacetic acid production. High purity pharmaceutical intermediates with reduced toxic waste and scalable manufacturing processes.
Patent CN102850314B enables aqueous ionic liquid catalysis for benzoxanthene derivatives ensuring high purity and scalable environmentally friendly manufacturing processes for global supply chains.
Patent CN110092753B reveals a high-yield 4-step synthesis for 3-azabicyclo[4.1.0]heptane-2-carboxylic acid, offering significant cost reduction and scalable supply chain solutions.
Patent CN107151246B reveals cost-effective chiral resolution. Reliable supplier for high-purity levo-praziquantel intermediates with scalable processes.
Novel sulfonamide route for 2-chloro-6-bromoaniline. High yield, mild conditions, cost-effective manufacturing for global supply chains and procurement.
Advanced 5-step synthesis of FTY720 intermediate via patent CN1814583A. Offers significant cost reduction and high purity for immunosuppressant manufacturing.
Patent CN102391169B offers high-purity BPH intermediate synthesis. Ether solvent method ensures safety and scalability for pharmaceutical supply chains.
Novel Heck reaction synthesis for Ramelteon intermediate offers high yield and scalable production for reliable pharmaceutical intermediates supplier partnerships.
Advanced anhydrous synthesis of Aripiprazole Lauroxil via paraformaldehyde. Delivers high-purity antipsychotic prodrugs with improved yields and cost reduction in API manufacturing.
Patent CN110396072B details a cost-effective dual-catalyst route for (S)-3-hydroxytetrahydrofuran, offering high optical purity and scalable manufacturing for global pharmaceutical supply chains.
Patent CN116768938B reveals iron catalyst technology for Rimegepant intermediates. Offers cost reduction and scalable supply chain solutions for pharmaceutical manufacturing.
Patent CN112979563B details a recyclable ionic liquid method for high-purity pharmaceutical intermediates, offering significant cost reduction and simplified purification for global supply chains.
Novel 4-step metal-free synthesis of Fevipiprant intermediate. Reduces cost and improves purity for asthma drug manufacturing via patent CN108484595B.